Paradigm Biocapital Advisors LP Purchases in Q3 2024

Paradigm Biocapital Advisors LP

  • $2.77 Billion
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
NUVL
Nuvalent, Inc.

Healthcare
428K
+ 9.37%
$67.44 - $112.17 $28.9M - $48M
5M $512M
ACLX
Arcellx, Inc.

Healthcare
152K
+ 3.95%
$50.91 - $86.61 $7.73M - $13.2M
4M $334M
VERA
Vera Therapeutics, Inc.

Healthcare
1.1M
New
$34.09 - $46.71 $37.4M - $51.2M
1.1M $48.5M
MLTX
Moon Lake Immunotherapeutics

Healthcare
931K
New
$40.15 - $55.4 $37.4M - $51.6M
931K $47M
BGNE
Bei Gene, Ltd.

Healthcare
200K
New
$143.93 - $224.51 $28.8M - $45M
200K $45M
JANX
Janux Therapeutics, Inc.

Healthcare
836K
+ 53.45%
$35.29 - $50.26 $29.5M - $42M
2.4M $109M
RVMD
Revolution Medicines, Inc.

Healthcare
55K
+ 1.05%
$36.92 - $47.94 $2.03M - $2.64M
5.31M $241M
PLRX
Pliant Therapeutics, Inc.

Healthcare
3.1M
New
$10.52 - $14.35 $32.7M - $44.5M
3.1M $34.8M
EWTX
Edgewise Therapeutics, Inc.

Healthcare
464K
+ 19.94%
$15.88 - $29.5 $7.36M - $13.7M
2.79M $74.4M
KROS
Keros Therapeutics, Inc.

Healthcare
525K
New
$41.68 - $58.07 $21.9M - $30.5M
525K $30.5M
COGT
Cogent Biosciences, Inc.

Healthcare
985K
+ 27.19%
$8.24 - $11.48 $8.12M - $11.3M
4.61M $49.8M
CRNX
Crinetics Pharmaceuticals, Inc.

Healthcare
3.38K
+ 0.13%
$43.83 - $54.98 $148K - $186K
2.52M $129M
TARS
Tarsus Pharmaceuticals, Inc.

Healthcare
5.03K
+ 0.21%
$21.54 - $34.6 $108K - $174K
2.44M $80.3M
ERAS
Erasca, Inc.

Healthcare
3.42M
+ 47.15%
$2.17 - $3.28 $7.42M - $11.2M
10.7M $29.1M
CGEM
Cullinan Oncology, Inc.

Healthcare
778K
+ 50.44%
$16.03 - $20.86 $12.5M - $16.2M
2.32M $38.9M
YMAB
Y M Abs Therapeutics, Inc.

Healthcare
216K
+ 5.57%
$9.95 - $15.39 $2.15M - $3.32M
4.09M $53.7M
IMTX
Immatics N.V.

Healthcare
483K
+ 14.11%
$10.93 - $12.92 $5.28M - $6.24M
3.9M $44.6M
MRUS
Merus N.V.

Healthcare
435K
+ 21.54%
$47.19 - $58.84 $20.5M - $25.6M
2.45M $123M
Spyre Therapeutics Inc
1.27M
New
N/A
1.27M $0
Oruka Therapeutics Inc
720K
New
N/A
720K $0
Apogee Therapeutics Inc
372K
+ 112.67%
N/A
702K $0
Activity Summary
Buys All Purchases 22 New Holdings 7 Increased Positions 15 Sells All Sells 7 Reductions 7 Sold out 0 Options Calls 2 Puts 0
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email